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Abstract Protein surface roughness is a structural prop-
erty associated with ligand-protein and protein-protein
binding interfaces. In this work we apply for the first
time the concept of surface roughness, expressed as the
fractal dimension, to address structure and function of G
protein-coupled receptors (GPCRs) which are an impor-
tant group of drug targets. We calculate the exposure
ratio and the fractal dimension for helix-forming resi-
dues of the β2 adrenergic receptor (β2AR), a model
system in GPCR studies, in different conformational states:
in complex with agonist, antagonist and partial inverse
agonists. We show that both exposure ratio and roughness
exhibit periodicity which results from the helical struc-
ture of GPCRs. The pattern of roughness and exposure
ratio of a protein patch depends on its environment: the
residues most exposed to membrane are in general most
rough whereas parts of receptors mediating interhelical
contacts in a monomer or protein complex are much smooth-
er. We also find that intracellular ends (TM3, TM5, TM6
and TM7) which are relevant for G protein binding and
thus receptor signaling, are exposed but smooth. Map-
ping the values of residual fractal dimension onto re-
ceptor 3D structures makes it possible to conclude that
the binding sites of orthosteric ligands as well as of choles-
terol are characterized with significantly higher roughness
than the average for the whole protein. In summary, our
study suggests that identification of specific patterns of
roughness could be a novel approach to spot possible binding
sites which could serve as original drug targets for GPCRs
modulation.
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Introduction
The concept of fractal geometry as a tool for describing
objects in nature was elaborated by Mandelbrot [1]. A
fractal can be considered as a rough geometric shape that
can be divided into fragments, each of them representing a
reduced copy of the whole. The extension of the concepts of
fractal geometry toward life sciences has led to significant
progress in understanding complex structural and functional
features of tissues, cells and molecules. In particular, the
concepts of fractal geometry have been applied to the de-
scription of structure and function of proteins [2]. The
fractal geometry of the protein surface manifests itself in
distinct global and local patterns of surface roughness. This
peculiar feature of the protein surface determines the first
level of communication with its surroundings in terms of
diffusion, molecule recognition, and physical properties [3].
As a result, surface roughness can be a useful tool to
describe and understand protein-protein and ligand-protein
interactions [4–6].
Although the concepts of fractal geometry have been
extensively used for the description of protein properties
[2, 4–9], they have never been applied to G protein-
coupled receptors (GPCRs). GPCRs are a group of medic-
inally important membrane proteins [10–13] which consti-
tute drug targets for about 50 % of all lately launched drugs
[14]. In the last years tremendous progress has been made in
the research on GPCRs. X-ray structures of some GPCRs
became available [15–21], including the structure of the β2
adrenergic receptor (β2AR) [20] and the adenosine A2A
receptor (A2AR) [21] in their active state. However, despite
these efforts in understanding receptor structure and func-
tioning (ligand binding, allosteric binding sites, protein-
protein interaction), many aspects still remain unknown.
Here, to address some of these aspects, we apply for the
first time the concept of the fractal dimension for quantify-
ing surface roughness of different conformational states of
the β2AR in complex with an agonist, an antagonist and two
partial inverse agonists (see workflow, Fig. 1). Quantitative-
ly, surface roughness, expressed as the fractal dimension [7,
8], df, is obtained by calculating solvent excluded surface
(SES) using differently-sized probes (Fig. 1) [7]. We also
use the SES to calculate the exposure ratio. Exposure ratio
indicates how much a residue is exposed on the protein
surface or buried in the protein interior. Our study shows
that the pattern of SES and exposure ratio exhibits a periodic
curve progression which is associated with the helical fea-
ture of the transmembrane (TM) domains in GPCRs. This
finding is in agreement with previous observations for TM
proteins [8]. Furthermore, we find that surface roughness as
well as exposure ratio capture some characteristic features of
active and inactive receptor conformations (see workflow,
Fig. 1). Another important observation of our study is that
surface roughness expressed as the fractal dimension is
significantly different at the binding site of small molecules
when compared to the average fractal dimension for the
whole receptor. As a result, we suggest that the fractal
dimension could be a useful parameter when searching for
novel binding sites of GPCRs in drug discovery.
Materials and methods
Studied X-ray structures
Four X-ray structures of the β2AR in different conforma-
tional states were studied: in complex with partial inverse
agonists carazolol (PDB ID: 2RH1 [15]) and timolol (PDB
ID: 3D4S [16]), the neutral antagonist alprenolol (PDB ID:
3NYA [17]) and an agonist (PDB ID: 3P0G [20]).
For the purpose of further computations all accompanying
molecules were removed. Hydrogen atoms were added and
optimized with Yasara Structure [22, 23].
Calculation of exposure ratio and the fractal dimension
as a measure of surface roughness
Exposure ratio and fractal dimension were calculated fol-
lowing the methodology of Renthal [8].
Exposure ratio (ER) First, the solvent-excluded surface was
calculated for each atom from the atomic coordinates of the
folded protein structure (SESFP, Fig. 1) using the MSMS
software [24]. Then, analogous calculation was performed
for isolated helices (SESIH, Fig. 1). In both cases a probe of
2.0 Å was used. The atomic contributions of SES were
summed into values per residue. The exposure ratio of a given
residue was obtained by the division of the corresponding SES
value in the folded protein by its SES value in the isolated helix
(SESFP/SESIH). The exposure ratio for a helix was calculated
as the average of exposure ratios of the respective residues
along with the standard deviation (SD). Exposure ratio was
calculated for all helix-forming residues of the β2AR.
Surface roughness
Surface roughness is proportional to the fractal dimension,
which can be calculated according to the following formula:
df ¼ 2 dlogSESdlogr ; ð1Þ
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where r denotes a probe size. Thus, in this case SES was
calculated with a set of different probe radii: 1.2; 1.4;
1.6; 1.8; 2.0; 2.2; 2.4; 2.6; 2.8 Å. Following the meth-
odology of Renthal [8], the value of a given residue
was obtained by summing atomic contributions of resi-
dues forming a patch on the surface of the helix. This
patch for a residue number N included sequence posi-
tions N-4, N-3, N, N+3, and N+4 which are neighbor-
ing residues resulting from the helical structure. The
differential term in Eq. 1 was gained by plotting SES over
probe size and application of linear regression to calculate the
slope of the graph. The roughness of a helix was calculated as
the average of roughness of respective residues, accompanied
by the standard deviation (SD). Surface roughness was calcu-
lated for all the helix-forming residues of the β2AR except for
the first four and the last four residues of each helix as
described above.
In the case of exposure ratio and surface roughness
data were processed using R [25] and Bio3d package
[26].
Mapping of roughness into receptors’ 3D structure
The obtained residual values of roughness were mapped
into the protein 3D structure with VMD [27]. The
residues forming small molecule binding sites were
detected with the Molecular Operation Environment
(MOE) [28] tool for identification of intermolecular
contacts.
Results and discussion
In order to assess the concept of the fractal dimension as a
tool for quantifying surface roughness (workflow, Fig. 1),
we selected four different conformational states of the β2AR
in complex with partial inverse agonists carazolol (PDB ID:
2RH1 [15]) and timolol (PDB ID: 3D4S [16]), the neutral
antagonist alprenolol (PDB ID: 3NYA [17]) and an agonist
(PDB ID: 3P0G [20]). The main structural difference be-
tween the different X-ray structures of the 7TM β2AR are
found in the intracellular TM ends (Fig. 2, structural inset).
In the active structure of the β2AR (PDB ID: 3P0G) the
intracellular side of the receptor (site of G protein binding) is
much more open in comparison to the inactive β2AR con-
formation (PDB IDs: 2RH1, 3D4S, and 3NYA, Fig. 2,
structural inset). This is due to the 11.4 Å outward move-
ment of TM6 present in the active structure. In the first step,
we calculate surface roughness as well as exposure ratio for
all four GPCR structures. In the second step, we compare
active and inactive β2AR states to assign distinct roughness
and exposure patterns to a particular receptor state. Finally,
we investigate the characteristics of surface roughness at
known small molecule binding sites of GPCRs.
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calculation of surface roughness
and exposure ratio for different
conformational states of the
β2AR
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Exposure ratio of β2AR residues in different conformational
states
The calculation of exposure ratio of helix-forming residues
for each transmembrane segment is described in detail in the
Materials and methods section. Table 1 presents the average
exposure ratio of all seven TMs of four conformational
states of β2AR.
The data show that independently from the conforma-
tional state of the β2AR, the most buried transmembrane
segments are TM2 and TM3, whereas the most exposed
ones are TM1, TM4 and to a lesser extent TM5, TM6 and
Fig. 2 Top left: structural superimposition of the active (PDB ID: 3P0G)
and the inactive (PDB ID: 2RH1) β2AR showing both receptors from the
intracellular side as well as two structural insets in surface representation
highlighting differences between the inactive and the active β2AR.
Bottom left to right: exposure ratio of residues of TMs 1 – 7 for different
conformational states of the β2AR. Blue lines correspond to inactive
structures (PDB IDs: 2RH1, 3D4S, 3NYA) whereas the red line corre-
sponds to the active structure (PDB ID: 3P0G)
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TM7. Such a pattern of helix exposure is a characteristic
signature of the GPCR architecture. The most buried seg-
ments, TM2 and TM3, are to the greatest extent involved in
interhelical interactions within the 7TM bundle. The TMs
which are more exposed may be involved in interactions
with different molecules, including oligomerization with
another GPCR. Indeed, the data about dimerization interfa-
ces of GPCRs indicate most frequently the involvement of
TM4 and TM5 [29]. TM5-TM6 interface occurs in the
crystal structure of the recently obtained chemokine CXCR4
dimer, termed the first functional dimer of a GPCR [30]. For
some receptors, TM1 [29] and TM6 [31] were also identi-
fied as the most probable oligomerization interface. Also,
multiple oligomerization interfaces are possible as found in
the semiempirical model of rhodopsin oligomer [32, 33].
This model involves TM1, TM2, TM4, and TM5 employing
the most exposed TM regions for protein-protein contacts.
Interestingly, the highest difference in the exposure ratio
for one particular TM among different conformational
β2AR states is found for TM6 (Table 1). TM6 is much more
exposed (exposure ratio of 0.6238) in the active state of the
β2AR than in any of the inactive states (exposure ratio
0.4648 – 0.4878). This finding is connected with the
11.4 Å outward movement of the cytoplasmic end of TM6
(Fig. 2, structural inset) during the process of receptor
activation [20]. Two other TMs that rearrange during the
receptor activation are TM5 and TM7 [20]. Comparison of
the exposure ratio of TM7 in the considered conformational
states of the β2AR reveals that TM7 is more buried in the
active conformation (exposure ratio of 0.4579) than in the
inactive conformations (exposure ratio in the range of
0.4816 – 0.5189). In contrast, TM5 does not show a clear
relationship at first glance: the exposure ratio of TM5 in the
active state (0.5960) is comparable to the respective expo-
sure in the β2AR-carazolol complex (0.6047) and slightly
higher than of other inactive conformations (0.5647 and
0.5674). More details are obtained by plotting the exposure
ratio of residues for each individual TM segment (TM 1 to
7) in different conformational of β2AR states (Fig. 2). First,
a clear periodicity of exposure ratio is seen for all confor-
mational β2AR states. This periodicity is a characteristic
feature of the seven transmembrane α-helical bundle and
results from the structural features of α-helices which pos-
sess periodicity of 3.6 residues per turn. It means that for
transmembrane helices with one face buried in the protein
core and the other exposed to the membrane, the residues at
helix positions i, i+3, i+4 and i+7 will lie on one face of the
helix (e.g., buried in a protein interior) whereas i+1, i+2, i+
5 and i+6 will lie on the other face (e.g., exposed to the
membrane). As a consequence, a characteristic alternation
of buried and exposed residues is observed when plotting
the exposure of an α-helical bundle, as shown in Fig. 2.
Nevertheless, there are subtle differences in the exposure
ratio of most residues when comparing an active conforma-
tion (PDB ID: 3P0G, Fig. 2, red line) with the inactive ones
(PDB IDs: 3D4S, 2RH1, 3NYA, Fig. 2, blue lines), due to
different receptor conformations. Major differences between
active and inactive structures are found in intracellular ends
of TM3, TM5, TM6 and TM7 whereas differences between
the three inactive conformations (blue lines) are much
smaller. For instance, we observe in TM3 that the exposure
ratio of residue Arg1313.50 (superscripts indicate
Ballesteros-Weinstein numbering for conserved GPCR res-
idues) [34], which forms a part of the ionic lock at the
intracellular TM end, is much higher (0.8817) in active than
in inactive states (0.1464 – 0.2911). In contrast, the
Asp1303.49 which is located next to Arg1313.50 and is also
a part of the ionic lock has a similar exposure ratio in all four
conformational states of β2AR. Rationalizing this data using
the X-ray structures of the active and the inactive β2AR
(Fig. 2, structural inset), we find that the 11.4 Å outward
movement of TM6 is responsible for the observed exposure
values of Arg1313.50 and Asp1303.49. A surface representa-
tion of the inactive β2AR (Fig. 2, structural inset down left)
Table 1 The average exposure ratio accompanied by the standard deviation (SD) of seven transmembrane segments of the β2AR in different
conformational states








TM1 0.6160±0.3655 0.6666±0.3538 0.6362±0.3577 0.6550±0.3419
TM2 0.3563±0.3032 0.3629±0.3012 0.3446±0.3129 0.3612±0.3209
TM3 0.3003±0.2926 0.3127±0.2967 0.2516±0.3083 0.2921±0.3290
TM4 0.6449±0.3572 0.6312±0.3559 0.6429±0.3591 0.6119±0.3589
TM5 0.5647±0.3854 0.6047±0.3693 0.5674±0.3760 0.5960±0.3813
TM6 0.4648±0.2884 0.4878±0.3017 0.4662±0.3084 0.6238±0.3395
TM7 0.5189±0.3497 0.5092±0.3401 0.4816±0.3624 0.4579±0.3577
*The SD is calculated over a helical structure which is characterized by a periodic exposure progression (alternation of buried and exposed residues)
which consequently leads to relatively high SD values
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shows clearly that a 11.4 Å inward location of TM6 buries
both residues Asp1303.49 (lime spheres) and Arg1313.50
(yellow spheres). In contrast, a 11.4 Å outward movement
of TM6 as found in the active β2AR (Fig. 2, structural inset
down right) results in an exposure of Arg1313.50 (yellow
spheres) while Asp1303.49 (lime spheres) remains buried.
The same TM6 outward movement contributes to the gen-
eral high exposure ratio of the intracellular ends of TM3,
TM5, TM6 and TM7 (highlighted by dashed circles, Fig. 2)
of the active β2AR (red line) when compared to inactive
β2ARs (blue lines). In this context, it can also be shown that
different receptor types (β2AR, A2AR, and D3R) can be
considered to be in a similar conformational state when
complexed with an antagonist. This is due to these receptors
exhibiting a similar residue exposure ratio (unpublished
results). Therefore, besides an overall conserved tertiary
structure, even side chain conformations of functionally
important residues are evolutionary conserved.
Taking all data together, we suggest that functional resi-
dues of GPCRs adopt a different conformation in different
conformational states of the same receptor, while they adopt
a similar conformation in similar conformational states of
different receptors.
The fractal dimension (surface roughness) of the β2AR
residues in different conformational states
Following the methodology of Renthal [8], we calculated
the fractal dimension of helical residues of β2AR in differ-
ent conformational states. Quantitatively, surface roughness,
expressed as the fractal dimension, was obtained by calcu-
lating solvent excluded surface using nine differently-sized
probes (see Materials and methods section). The regression
coefficients (R2) of df versus the probe size were in all cases
above 0.95, most often above 0.98. Table 2 shows the average
roughness of seven TMs of the β2AR in the considered
conformations.
The roughness values (roughness range: 2.0964 – 2.1338,
Table 2) reveal a tendency for certain TM helices to be
smoother or rougher among different conformational states
of the β2AR. For instance, it can be seen that TM2 is the
smoothest whereas TM7 is the roughest one (Table 2). In-
terestingly, comparing the obtained surface roughness with
the before calculated exposure ratio, we find that one of the
smoothest helices, TM2 is simultaneously one of the most
buried within our series of GPCRs (Table 1, Fig. 3). In
contrast, the roughest TM7 is simultaneously the most ex-
posed to the lipid environment (Table 1, Fig. 3). These
findings are consistent with Renthal’s [8] reports that in
the case of transmembrane α-helical proteins the smoothest
residues are mainly buried and participate in intra-helical
protein-protein interactions whereas the roughest residues
are those that are exposed, interacting with membrane lipids.
This can be justified, as follows, by thermodynamic reasons.
All addressed crystal structures were obtained under com-
parable crystallization conditions, that is, in a lipid environ-
ment rich in fatty acids and cholesterol [15–21]. Such
medium stabilizes the receptor in its naturally occurring
7TM architecture by mimicking the lipid membrane envi-
ronment. Alkyl chains of lipids, when situated adjacent to a
rough surface, adopt a thermodynamically favored confor-
mation that is rich in kinks (i.e., gauche-trans-gauche). This
is less common when alkyl chains are packed against a
smooth surface instead [8]. Thus, the entropy of alkyl chains
increases when they neighbor with a rough protein surface
in comparison with a smooth one. Furthermore, by interact-
ing along smooth surfaces, transmembrane helices exclude
these regions from the interaction with lipids which
decreases the free energy of a membrane. In contrast,
smooth residues are likely responsible for interhelical con-
tacts [8].
Besides TM2, TM3 is also a highly buried helix, but
exhibits relatively high roughness (average fractal dimen-
sion in the range of 2.1251 – 2.1324). This is connected with
Table 2 The average fractal dimension (surface roughness) accompanied by the standard deviation (SD) of seven transmembrane segments of the
β2AR in different conformational states








TM1 2.1244±0.0303 2.1338±0.0396 2.1139±0.0271 2.1318±0.0312
TM2 2.1009±0.0257 2.1008±0.0239 2.0964±0.0329 2.1136±0.0226
TM3 2.1322±0.0439 2.1305±0.0437 2.1324±0.0486 2.1251±0.0335
TM4 2.1168±0.0345 2.1192±0.0361 2.1317±0.0429 2.1192±0.0420
TM5 2.1214±0.0469 2.1106±0.0359 2.1245±0.0472 2.1225±0.0409
TM6 2.1134±0.0341 2.1133±0.0441 2.1111±0.0392 2.1077±0.0414
TM7 2.1335±0.0321 2.1303±0.0341 2.1306±0.0423 2.1194±0.0472
*The SD is calculated over a helical structure which is characterized by a periodic roughness progression (alternation of rougher and smoother
residues) which consequently leads to relatively high SD values
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the fact that TM3 contains various residues of the rough
orthosteric binding site of the receptor (Trp1093.28,
Asp1133.32, Val1143.33, Val1173.36, Thr1183.37), as discussed
below.
The complete roughness pattern of each TM for β2ARs
in different conformational states is plotted in Fig. 4. Sim-
ilarly to the exposure ratio, roughness reveals a periodic
pattern. This characteristic feature has to be ascribed to the
peculiar structural properties of the 7TM helical bundle of
GPCRs in which residues are alternating exposed to lipid
(rougher) and neighbor helices (smoother) (see section:
Roughness versus exposure ratio). Interestingly, the rough-
ness profile between conformationally different structures
(PDB IDs: 2RH1, 3D4S, 3NYA, 3P0G, Fig. 4) varies much
more than the profile of the exposure ratio (Fig. 2). Even
within the group of inactive structures (PDB IDs: 2RH1,
3D4S, 3NYA, Fig. 4, blue lines) the roughness profile is less
conserved, particularly for TM 1 to 4. Apparently, the cal-
culation of the surface roughness captures more detail of
conformational differences even within inactive receptors
than exposure ratio. Rather conserved roughness regions
for the inactive structures (Fig. 4, blue lines) are found in
TM5, TM6 and TM7. In this case, the active conformation
of the β2AR (Fig. 4, red line) is clearly distinct from the
inactive ones (blue lines). The roughness plot (Fig. 4)
reveals flattened regions on the intracellular end of TM5,
TM6 and TM7 for the active state of the β2AR (Fig. 4, red
line) when compared to the inactive structures (Fig. 4, blue
lines). Interestingly, the altered intracellular region consisting
Fig. 3 Roughness pattern of the alprenolol-bound β2AR (PDB ID:
3NYA): TM2 is smoother (reddish) than TM7 (greenish)
Fig. 4 Fractal dimension (surface roughness) of residues of TMs 1 – 7
for different conformational states of the β2AR. Blue lines correspond to
inactive structures (PDB IDs: 2RH1, 3D4S, 3NYA) and the red line to the
active structure (PDB ID: 3P0G)
b
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of the N-terminus of TM6 and C-terminus of TM5 and
TM7 binds normally to the G-protein in the active β2AR
(PDB ID: 3P0G). In contrast, in the inactive β2AR, the
N-terminus of TM6 and the C-terminus of TM5 and TM7 is
partially involved in intramolecular contacts as well as par-
tially exposed to solvent interactions entering from the intra-
cellular receptor side.
Roughness versus exposure ratio
We have shown above for GPCRs that both the exposure
ratio and the surface roughness expressed as the fractal
dimension exhibit a periodic pattern (Figs. 2 and 4). Com-
parison of the pattern of the exposure ratio and the rough-
ness for the inactive β2AR (Fig. 5) shows that in most cases
the most exposed residues are simultaneously the most
rough although a phase shift is observed [8]. However,
meaningful exceptions occur in the active form of the
β2AR (PDB ID: 3P0G), where residues of the intracellular
ends of TM5, TM6 and TM7 are exposed but smooth
(Fig. 5, labeled by boxes). These exceptions coincide with
receptor regions which interact with the G protein-
mimicking nanobody (PDB ID: 3P0G). Such smoothened
and exposed protein surface is in agreement with Renthal´s
findings who demonstrated that protein-protein interfaces
are characterized with lower roughness than the average of
transmembrane receptor [8].
Our results show that G-protein binding is responsible for
the change in the roughness pattern on the intracellular end
of TM helices. Moreover, our study suggests that roughness
pattern is a valuable parameter to spot the interface of
protein-protein binding as well as to allow distinguishing
between active and inactive GPCRs.
The values of the exposure ratio and the fractal dimen-
sion presented in Tables 1 and 2 are characterized by high
standard deviations. The standard deviation is a measure of
the dispersion of a variable diversity. It shows how much the
values of this variable vary from the average value. As both
the exposure ratio and the fractal dimension exhibit periodic
progression of high and low values, the values of these
Fig. 5 Roughness (blue) versus exposure ratio (red) of TM5, 6 and 7 of active and inactive forms of the β2AR
Fig. 6 Roughness of the orthosteric binding site for different confor-
mational states of the β2AR. a – d: orthosteric binding site in complex
with inverse agonist timolol a and carazolol b, antagonist alprenolol c
and agonist d. Residues in direct contact with the ligand are shown in
surface whereas residues within 4.5 Å but not in direct contact are
shown in licorice
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parameters are highly differentiated. In the case of the expo-
sure ratio the values range from 0 (for completely buried
residues) to 1 (for completely exposed residues) resulting in
a high diversity within the data set and, in consequence, in
high values of the standard deviation. Similarly, the diversity
of the fractal dimension leads in turn to relatively high values
of the standard deviation for this parameter too.
Roughness of orthosteric and cholesterol binding sites
of the β2AR
The surface roughness was calculated for classical orthos-
teric binding site and the experimentally observed choles-
terol binding site at TM4. The cholesterol consensus motif
at TM4 is present in about 26 % of GPCRs [16] and has
been proposed to modulate protein function through direct
and specific interaction with GPCRs [35].
Residues forming the orthosteric and the cholesterol
binding sites were indentified using the MOE software
[28] by taking into account a 4.5 or 8 Å-region around the
ligand (Figs. 6 and 7, shown in licorice). Thereby, residues
with direct ligand contacts were detected by applying the
“protein contacts” tool of MOE software (Figs. 6 and 7,
surface representation). Subsequently, roughness was calcu-
lated for the complete binding site omitting helix termini
and loops; roughness values of direct-interacting residues
are collected in Table 3.
The obtained data for orthosteric binding sites of different
β2AR structures (Table 3) shows clearly that the average
roughness values for residues interacting directly with timo-
lol (PDB ID: 3D4S), carazolol (PDB ID: 2RH1), alprenolol
(PDB ID: 3NYA), and an agonist (PDB ID: 3P0G) are
higher (2.1521 – 2.1592) than the average for the whole
receptor (exposed residues: 2.1196 – 2.1227). Furthermore,
mapping the obtained roughness values onto the 3D struc-
ture using VMD [27] reveals that only direct-interacting
residues (Fig. 6, a – d, surface representation) are rough
(white to green). In contrast, not direct-interacting residues
(Fig. 6, a – d, licorice representation), that are within 4.5 Å
of the ligand, are mainly smooth (white to red color). Note-
worthy, no significant roughness differences in the orthos-
teric sites (Fig. 6, a – d; Table 3: 2.1521 – 2.1592) are found
between active (PDB ID: 3POG) and inactive (PDB IDs:
3D4S, 2RH1, 3NYA) conformations of β2ARs .
A similar tendency is found for the cholesterol binding
sites at TM4 (Table 3). The roughness of this cholesterol
binding site for the β2ARs adopts values from 2.1303 to
2.1679 which are also higher than the average of the recep-
tor (exposed residues: 2.1196 – 2.1227). An interesting
observation is that the active β2AR (PDB ID: 3P0G) has
the lowest roughness of 2.1303 compared to the inactive
β2ARs, from 2.1424 to 2.1679. Indeed, plotting the rough-
ness onto all cholesterol binding sites reveals an altered
roughness pattern for active (Fig. 7d) and inactive β2ARs
(Fig. 7, a – c).
Fig. 7 Roughness of the cholesterol binding site for different conforma-
tional states of the β2AR. a – d: orthosteric binding site in complex with
inverse agonists timolol a and carazolol b, antagonist alprenolol c and
agonist d. Residues in direct contact with the ligand are shown in surface
whereas residues within 8 Å but not in direct contact are shown in
licorice. The dotted circle highlights differences in the roughness pattern
Table 3 Average roughness of the β2AR in different conformational states accompanied by the standard deviation (SD) for the orthosteric and the
cholesterol binding sites at TM4
3D4S 2RH1 3NYA 3P0G
Complete receptor (exposed residues) 2.1215±0.0347 2.1210±0.0363 2.1227±0.0416 2.1196±0.0352
Orthosteric binding site Trp1093.28, Asp1133.32,
Val1143.33, Val1173.36, Ser2035.42, Phe2896.51,
Phe2906.52, Asn3127.39, Tyr3167.43
2.1567±0.0501 2.1521±0.0424 2.1572±0.0577 2.1592±0.0367
Cholesterol binding site (TM4) Val812.52, Phe1083.27,
Ile1123.31, Leu1153.34, Ile1544.46, Trp1584.50
2.1424±0.0400 2.1430±0.0411 2.1679±0.0317 2.1303±0.0394
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Thereby, the cholesterol binding site of the active β2ARs
shows a smoother patch in the middle of the direct interact-
ing residues (Fig. 7d, dotted circle) whereas the inactive
ones are rougher (Fig. 7, a – c, dotted circle). This interest-
ing finding can be linked to the fact that the active β2ARs
has no cholesterol bound in the X-ray structure (PDB ID:
3P0G). The observed difference of roughness pattern points
to a cholesterol binding-induced alteration of roughness.
This is supported by another observation, that a different
binding pose of cholesterol affects the roughness pattern. In
the inactive β2ARs bound to timolol and alprenolol, the
cholesterol interacts with a rougher protein surface through
its “rough side”, that is, the side with methyl groups in the
sterol ring (Fig. 7a and c). On the contrary, in the inactive
carazolol-bound β2AR, the “smooth side” of the cholesterol
interacts with a smoother protein surface (Fig. 7b). There-
fore, the way cholesterol binds to the protein induces a
particular roughness pattern. These differences indicate that
surface roughness is a dynamic property of GPCRs.
Conclusions
In this study, we apply for the first time the concept of
surface roughness calculated as the fractal dimension for
GPCRs. Surface roughness is an important property of
proteins that can be linked to the architecture and function
of proteins. Our study shows that both exposure ratio and
fractal dimension are periodic features of GPCRs describing
the 3D architecture of a 7TM helical bundle. Such period-
icity is a result of the peculiar structural properties of the
7TM α-helical bundle of GPCRs, where residues are alter-
natively exposed to neighbor helices and lipid molecules.
Thereby, buried residues interacting with neighbor helices
are smooth whereas residues exposed to lipids are rather
rough. Exceptions near the intracellular TM ends occur when
the inactive β2AR adopts an active state. Hereby, roughness
calculations clearly identify the region of G-protein binding, a
key zone for GPCR signaling.
Moreover, our study indicates that also binding site for
small molecules are detectable by roughness calculations.
The classical orthosteric binding site as well as the experi-
mentally observed cholesterol site at TM4 are significantly
rougher than the average of the β2AR.
Finally, we prove that roughness is not a static but a
dynamic property since the cholesterol binding/non-binding
process, the cholesterol binding pose as well as G protein
binding alter the surface roughness.
All in all, our results suggest that the calculation of
roughness pattern may be a useful tool to identify protein
binding sites as we determined that small molecule binding
sites have higher fractal dimension than the average for the
whole protein. Thus, our study suggests that studying
surface roughness could become an interesting approach
for detecting novel binding sites which is of high interest for
drug discovery.
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